← Back to Search

Diagnostic Test

Evaluation of Performance of the LumiraDx Influenza A/B + RSV Test at POC Testing Sites (INSPIRE Trial)

N/A
Recruiting
Led By Song Yu
Research Sponsored by LumiraDx UK Limited
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 months
Awards & highlights
No Placebo-Only Group

Summary

This trial looked at how well the LumiraDx test works for Influenza A/B and RSV at various point of care testing sites.

Eligible Conditions
  • Flu-Related Pain
  • Flu
  • Respiratory Syncytial Virus Infection
  • Respiratory Syncytial Virus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Performance evaluation by health care professionals
Performance evaluation by non-laboratory users

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Nasopharyngeal swabExperimental Treatment1 Intervention
Nasopharyngeal swab from subjects with signs and symptoms of influenza and/or RSV-like illness
Group II: Nasal swabExperimental Treatment1 Intervention
Nasal swab from subjects with signs and symptoms of influenza and/or RSV-like illness
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Swab
2019
N/A
~100

Find a Location

Who is running the clinical trial?

LumiraDx UK LimitedLead Sponsor
15 Previous Clinical Trials
32,490 Total Patients Enrolled
Song YuPrincipal InvestigatorMedHelp Urgent Care
Michael BellPrincipal InvestigatorAccel-West Volusia Pediatrics
Christina UlenPrincipal InvestigatorAdvanced Pediatrics
Robert RosenPrincipal InvestigatorArdmore Family Practice
1 Previous Clinical Trials
1,134 Total Patients Enrolled
Ramin FarsadPrincipal InvestigatorAccess Medical Center
1 Previous Clinical Trials
668 Total Patients Enrolled
Matthew MorganPrincipal InvestigatorCentura Health Physician Group
2 Previous Clinical Trials
353 Total Patients Enrolled
Andre GvozdenPrincipal InvestigatorGvozden Pediatrics
1 Previous Clinical Trials
1,134 Total Patients Enrolled
Nader NakhlehPrincipal InvestigatorJersey Shore UMC
Lisa ConneryPrincipal InvestigatorLisa Connery MD

Media Library

Swab (Diagnostic Test) Clinical Trial Eligibility Overview. Trial Name: NCT04288921 — N/A
Flu-Related Pain Research Study Groups: Nasopharyngeal swab, Nasal swab
Flu-Related Pain Clinical Trial 2023: Swab Highlights & Side Effects. Trial Name: NCT04288921 — N/A
Swab (Diagnostic Test) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04288921 — N/A
~343 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top